Modulation of coronary artery disease risk factors by menopausal status: A population based study among Iranian women (KERCADRStudy)

ARYA Atherosclerosis

Volumn 9, Issue 6, 2013, Pages 332-336

  Yousefzadeh, Gholamreza ^a   Mahdavi Jafari, Fatemeh ^b   Shokoohi, Mostafa ^c   Najafipour, Hamid ^a   Haghdoost, Ali Akbar ^c   Nejad, Vida Modares ^d  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CAD Risk Factors; Perimenopause; Postmenopause; Premenopause; Women

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; ANTHROPOMETRY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CLIMACTERIUM; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; QUESTIONNAIRE; RISK FACTOR; SMOKING;

EID: 84891278875     PISSN: 17353955     EISSN: 22516638     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gohlke-Barwolf C. Coronary artery disease--is menopause a risk factor? Basic Res Cardiol 2000; 95(Suppl 1): I77-I83.
2. Agrinier N, Cournot M, Dallongeville J, Arveiler D, Ducimetiere P, Ruidavets JB, et al. Menopause and modifiable coronary heart disease risk factors: a population based study. Maturitas 2010; 65(3): 237-43.
3. Razay G, Heaton KW, Bolton CH. Coronary heart disease risk factors in relation to the menopause. Q J Med 1992; 85(307-308): 889-96.
4. Dallongeville J, Marecaux N, Isorez D, Zylbergberg G, Fruchart JC, Amouyel P. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis 1995; 118(1): 123-33.
5. Schaefer EJ, Lamon-Fava S, Cohn SD, Schaefer MM, Ordovas JM, Castelli WP, et al. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res 1994; 35(5): 779-92.
6. Tremollieres FA, Pouilles JM, Cauneille C, Ribot C. Coronary heart disease risk factors and menopause: a study in 1684 French women. Atherosclerosis 1999; 142(2): 415-23.
7. Heiss G, Tamir I, Davis CE, Tyroler HA, Rifkand BM, Schonfeld G, et al. Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study. Circulation 1980; 61(2): 302-15.
8. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987; 114(2): 413-9.
9. Najafipour H, Mirzazadeh A, Haghdoost A, Shadkam M, Afshari M, Moazenzadeh M, et al. Coronary Artery Disease Risk Factors in an Urban and Peri-urban Setting, Kerman, Southeastern Iran (KERCADR Study): Methodology and Preliminary Report. Iran J Public Health 2012; 41(9): 86-92.
10. Merz CN, Kelsey SF, Pepine CJ, Reichek N, Reis SE, Rogers WJ, et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol 1999; 33(6): 1453-61.
11. thed. Paris, France: Éd du Vidal; 1994.
12. Sullivan JM, Fowlkes LP. Estrogens, menopause, and coronary artery disease. Cardiol Clin 1996; 14(1): 105-16.
13. Rossouw JE. Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones. Maturitas 2005; 51(1): 51-63.
14. Clarkson TB. The new conundrum: do estrogens have any cardiovascular benefits? Int J Fertil Womens Med 2002; 47(2): 61-8.
15. Holm P, Andersen HL, Andersen MR, Erhardtsen E, Stender S. The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium. A time course study in cholesterol-clamped rabbits. Circulation 1999; 100(16): 1727-33.
16. Kovanen PT, Brown MS, Goldstein JL. Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol. J Biol Chem 1979; 254(22): 11367-11373.
17. Nestel PJ, Hirsch EZ, Couzens EA. The effect of chlorophenoxyisobutyric acid and ethinyl estradiol on cholesterol turnover. J Clin Invest 1965; 44: 891-6.
18. Kushwaha RS, Hazzard WR. Effect of exogenous estrogens on catabolism of VLDL in cholesterol-fed rabbits. Am J Physiol 1981; 241(5): E372-E377.
19. Gierach GL, Johnson BD, Bairey Merz CN, Kelsey SF, Bittner V, Olson MB, et al. Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) Study. J Am Coll Cardiol 2006; 47(3 Suppl): S50-S58.
20. Rosenthal T, Oparil S. Hypertension in women. J Hum Hypertens 2000; 14(10-11): 691-704.
21. Rajkumar C, Kingwell BA, Cameron JD, Waddell T, Mehra R, Christophidis N, et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol 1997; 30(2): 350-6.
22. Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996; 28(4): 576-82.
23. Staessen JA, Celis H, Fagard R. The epidemiology of the association between hypertension and menopause. J Hum Hypertens 1998; 12(9): 587-92.